For instance, in glioblastoma tumor cells with high expression of BCL2 like 13 (BCL2L13), CERS2 activity is blocked, resulting in the prevention of apoptosis in response to both conventional and targeted therapies. This evidence concerns the gene CERS2 and glioblastoma.